In a research report issued today, William Blair analyst Brian Weinstein maintained a Market Perform rating on Meridian Bioscience (NASDAQ:VIVO). No price target was provided.
In a research note issued today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences Corporation (EXAS) ahead of CMS pricing and miscellaneous data points on early …
On Tuesday, July 29 Sequenom (SQNM) reported second quarter 2014 results that included revenue of $39.8 million, which was a bit shy of the consensus …
In a research note issued yesterday, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences Corporation (EXAS) on the heels of …
In a research note released Wednesday, William Blair analyst Brian Weinstein reiterated coverage on Exact Sciences Corporation (EXAS) with a Buy rating, after he spent the day at Exact Sciences’ headquarters in …
